These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 3606749

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Rhizoxin binding to tubulin at the maytansine-binding site.
    Takahashi M, Iwasaki S, Kobayashi H, Okuda S, Murai T, Sato Y.
    Biochim Biophys Acta; 1987 Dec 07; 926(3):215-23. PubMed ID: 3120782
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Interaction of phomopsin A with porcine brain tubulin. Inhibition of tubulin polymerization and binding at a rhizoxin binding site.
    Li Y, Kobayashi H, Tokiwa Y, Hashimoto Y, Iwasaki S.
    Biochem Pharmacol; 1992 Jan 22; 43(2):219-24. PubMed ID: 1739410
    [Abstract] [Full Text] [Related]

  • 5. Antimitotic and antitubulin activity of the tumor inhibitor steganacin.
    Wang RW, Rebhum LI, Kupchan SM.
    Cancer Res; 1977 Sep 22; 37(9):3071-9. PubMed ID: 560248
    [Abstract] [Full Text] [Related]

  • 6. Studies on macrocyclic lactone antibiotics. XIII. Anti-tubulin activity and cytotoxicity of rhizoxin derivatives: synthesis of a photoaffinity derivative.
    Kato Y, Ogawa Y, Imada T, Iwasaki S, Shimazaki N, Kobayashi T, Komai T.
    J Antibiot (Tokyo); 1991 Jan 22; 44(1):66-75. PubMed ID: 2001986
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In vitro and in vivo modulation by rhizoxin of non-P-glycoprotein-mediated vindesine resistance.
    Arioka H, Nishio K, Heike Y, Abe S, Saijo N.
    J Cancer Res Clin Oncol; 1997 Jan 22; 123(4):195-200. PubMed ID: 9177491
    [Abstract] [Full Text] [Related]

  • 9. Spongistatin 1, a highly cytotoxic, sponge-derived, marine natural product that inhibits mitosis, microtubule assembly, and the binding of vinblastine to tubulin.
    Bai R, Cichacz ZA, Herald CL, Pettit GR, Hamel E.
    Mol Pharmacol; 1993 Oct 22; 44(4):757-66. PubMed ID: 8232226
    [Abstract] [Full Text] [Related]

  • 10. Ustiloxins, new antimitotic cyclic peptides: interaction with porcine brain tubulin.
    Li Y, Koiso Y, Kobayashi H, Hashimoto Y, Iwasaki S.
    Biochem Pharmacol; 1995 May 17; 49(10):1367-72. PubMed ID: 7763278
    [Abstract] [Full Text] [Related]

  • 11. [Microtubules and antineoplastic drugs].
    Arioka H, Saijo N.
    Gan To Kagaku Ryoho; 1994 Apr 17; 21(5):583-90. PubMed ID: 7908790
    [Abstract] [Full Text] [Related]

  • 12. Interaction of marine toxin dolastatin 10 with porcine brain tubulin: competitive inhibition of rhizoxin and phomopsin A binding.
    Li Y, Kobayashi H, Hashimoto Y, Shirai R, Hirata A, Hayashi K, Hamada Y, Shioiri T, Iwasaki S.
    Chem Biol Interact; 1994 Dec 17; 93(3):175-83. PubMed ID: 7923438
    [Abstract] [Full Text] [Related]

  • 13. Preclinical antitumour activity and animal toxicology studies of rhizoxin, a novel tubulin-interacting agent.
    Hendriks HR, Plowman J, Berger DP, Paull KD, Fiebig HH, Fodstad O, Dreef-van der Meulen HC, Henrar RE, Pinedo HM, Schwartsmann G.
    Ann Oncol; 1992 Nov 17; 3(9):755-63. PubMed ID: 1450065
    [Abstract] [Full Text] [Related]

  • 14. Tubulin as a target for anticancer drugs: agents which interact with the mitotic spindle.
    Jordan A, Hadfield JA, Lawrence NJ, McGown AT.
    Med Res Rev; 1998 Jul 17; 18(4):259-96. PubMed ID: 9664292
    [Abstract] [Full Text] [Related]

  • 15. Rapid rate of tubulin dissociation from microtubules in the mitotic spindle in vivo measured by blocking polymerization with colchicine.
    Salmon ED, McKeel M, Hays T.
    J Cell Biol; 1984 Sep 17; 99(3):1066-75. PubMed ID: 6470037
    [Abstract] [Full Text] [Related]

  • 16. [Assessment of antitumor activity rhizoxin for human lung cancer cell lines: a potent new drug for drug-resistant lung cancer].
    Takigawa N, Ohnoshi T, Ueoka H, Horiguchi T, Kiura K, Tabata M, Segawa Y, Shibayama T, Genba K, Matsumura T.
    Gan To Kagaku Ryoho; 1993 Jul 17; 20(9):1221-6. PubMed ID: 8392827
    [Abstract] [Full Text] [Related]

  • 17. Rhizoxin resistant mutants with an altered beta-tubulin gene in Aspergillus nidulans.
    Takahashi M, Kobayashi H, Iwasaki S.
    Mol Gen Genet; 1989 Dec 17; 220(1):53-9. PubMed ID: 2691873
    [Abstract] [Full Text] [Related]

  • 18. Studies on macrocyclic lactone antibiotics. VII. Structure of a phytotoxin "rhizoxin" produced by Rhizopus chinensis.
    Iwasaki S, Kobayashi H, Furukawa J, Namikoshi M, Okuda S, Sato Z, Matsuda I, Noda T.
    J Antibiot (Tokyo); 1984 Apr 17; 37(4):354-62. PubMed ID: 6547134
    [Abstract] [Full Text] [Related]

  • 19. Natural products which interact with tubulin in the vinca domain: maytansine, rhizoxin, phomopsin A, dolastatins 10 and 15 and halichondrin B.
    Hamel E.
    Pharmacol Ther; 1992 Apr 17; 55(1):31-51. PubMed ID: 1287674
    [Abstract] [Full Text] [Related]

  • 20. Tumor selective effect of RS-1541 (palmitoyl-rhizoxin) in M5076 sarcoma and host tissues in vivo.
    Tokui T, Maeda N, Kuroiwa C, Sasagawa K, Inoue T, Kawai K, Ikeda T, Komai T.
    Pharm Res; 1995 Mar 17; 12(3):370-5. PubMed ID: 7617523
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.